Drug intelligence / Profile preview

rabies vaccine (Ningbo Rongan Biological Pharmaceutical Co., Ltd.)

Development stage
Approved
Lead developer
AIM Vaccine Co.
Modality
Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

The Freeze-dried Human Rabies Vaccine is an inactivated vaccine developed and manufactured by Ningbo Rongan Biological Pharmaceutical, a subsidiary of AIM Vaccines. It is produced using either Vero cell or human diploid cell technology to propagate the rabies virus, which is then inactivated and lyophilized for stability. The vaccine is indicated for both pre-exposure and post-exposure prophylaxis against rabies, a lethal zoonotic disease. It works by stimulating the immune system to produce virus-neutralizing antibodies that provide protective immunity. The vaccine is approved in China and has been evaluated in Phase III clinical trials using various immunization schedules, including the 5-dose, 4-dose, and 2-1-1 regimens, demonstrating high immunogenicity and a favorable safety profile.

Other names
Freeze-dried Human Rabies VaccineHuman Rabies Vaccine (Vero Cell)Human Rabies Vaccine (Human Diploid Cell)Freeze-dried Human Rabies Vaccine (Vero Cell)

Beyond the preview

Go deeper on rabies vaccine (Ningbo Rongan Biological Pharmaceutical Co., Ltd.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rabies vaccine (Ningbo Rongan Biological Pharmaceutical Co., Ltd.).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call